Clinical trial
Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation
NCT04919135 is registered in ClinicalTrials.gov with Vinmec Research Institute of Stem Cell and Gene Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation
- Lead sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 19, 2021
- Completion date
- December 30, 2024
- Enrollment
- 158 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.